AP3777A - - Google Patents
Info
- Publication number
- AP3777A AP3777A AP2014007413A AP2014007413A AP3777A AP 3777 A AP3777 A AP 3777A AP 2014007413 A AP2014007413 A AP 2014007413A AP 2014007413 A AP2014007413 A AP 2014007413A AP 3777 A AP3777 A AP 3777A
- Authority
- AP
- ARIPO
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/183,119 US8664265B2 (en) | 2005-05-18 | 2011-07-14 | Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials |
IN2703DE2011 | 2011-09-19 | ||
IN2156DE2012 | 2012-07-12 | ||
PCT/IB2012/053614 WO2013008218A1 (en) | 2011-07-14 | 2012-07-13 | Stable dosage forms of arterolane and piperaquine |
Publications (2)
Publication Number | Publication Date |
---|---|
AP2014007413A0 AP2014007413A0 (en) | 2014-02-28 |
AP3777A true AP3777A (ko) | 2016-08-31 |
Family
ID=47505579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2014007413A AP2014007413A0 (en) | 2011-07-14 | 2012-07-13 | Stable dosage forms of arterolane and piperaquine |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2731603A1 (ko) |
JP (1) | JP2014522856A (ko) |
KR (1) | KR20140053169A (ko) |
CN (1) | CN103930107A (ko) |
AP (1) | AP2014007413A0 (ko) |
AU (1) | AU2012282077A1 (ko) |
CA (1) | CA2850089A1 (ko) |
EA (1) | EA201490233A8 (ko) |
MX (1) | MX2014000463A (ko) |
WO (1) | WO2013008218A1 (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP2015008748A0 (en) | 2013-02-28 | 2015-09-30 | Sun Pharmaceutical Ind Ltd | Stable dispersible formulation of arterolane maleate and piperaquine and process of preparation thereof |
KR101698003B1 (ko) * | 2016-06-20 | 2017-01-19 | 여오영 | 퀴닌 염 현탁액을 포함하는 항암 치료를 위한 국소 투여용 주사제 조성물 |
BR112020011506A2 (pt) * | 2017-12-12 | 2020-11-17 | Intervet International B.V. | composições farmacêuticas de isoxazolina implantáveis e usos das mesmas |
CN116322688A (zh) * | 2020-08-14 | 2023-06-23 | 太阳制药工业有限公司 | 用于治疗疟疾的固定剂量的联合用药 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006123314A2 (en) * | 2005-05-18 | 2006-11-23 | Ranbaxy Laboratories Limited | Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials |
WO2007132438A2 (en) * | 2006-05-17 | 2007-11-22 | Ranbaxy Laboratories Limited | Antimalarial therapy using a combination of synthetic artemisinin derivative and bisquinoline derivative |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6486199B1 (en) | 2001-06-21 | 2002-11-26 | Medicines For Malaria Venture Mmv International Centre Cointrin | Spiro and dispiro 1,2,4-trioxolane antimalarials |
US6906205B2 (en) | 2002-06-21 | 2005-06-14 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trioxolane antimalarials |
US6825230B2 (en) | 2002-06-21 | 2004-11-30 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trixolane antimalarials |
-
2012
- 2012-07-13 AU AU2012282077A patent/AU2012282077A1/en not_active Abandoned
- 2012-07-13 JP JP2014519689A patent/JP2014522856A/ja active Pending
- 2012-07-13 AP AP2014007413A patent/AP2014007413A0/xx unknown
- 2012-07-13 EP EP12743776.2A patent/EP2731603A1/en not_active Withdrawn
- 2012-07-13 MX MX2014000463A patent/MX2014000463A/es unknown
- 2012-07-13 WO PCT/IB2012/053614 patent/WO2013008218A1/en active Application Filing
- 2012-07-13 CN CN201280044576.7A patent/CN103930107A/zh active Pending
- 2012-07-13 CA CA2850089A patent/CA2850089A1/en not_active Abandoned
- 2012-07-13 EA EA201490233A patent/EA201490233A8/ru unknown
- 2012-07-13 KR KR1020147003043A patent/KR20140053169A/ko not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006123314A2 (en) * | 2005-05-18 | 2006-11-23 | Ranbaxy Laboratories Limited | Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials |
WO2007132438A2 (en) * | 2006-05-17 | 2007-11-22 | Ranbaxy Laboratories Limited | Antimalarial therapy using a combination of synthetic artemisinin derivative and bisquinoline derivative |
Non-Patent Citations (2)
Title |
---|
SNYDER ET AL: "In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models", EXPERIMENTAL PARASITOLOGY, NEW YORK, NY, US, vol. 115, no. 3, 2 December 2006 (2006-12-02), pages 296 - 300, XP005724230 * |
VALECHA NEENA ET AL: "Arterolane Maleate Plus Piperaquine Phosphate for Treatment of Uncomplicated Plasmodium falciparum Malaria: A Comparative, Multicenter, Randomized Clinical Trial", CLINICAL INFECTIOUS DISEASES, vol. 55, no. 5, 14 May 2012 (2012-05-14), pages 663 - 671 URL, XP009163781 * |
Also Published As
Publication number | Publication date |
---|---|
AU2012282077A1 (en) | 2014-01-30 |
KR20140053169A (ko) | 2014-05-07 |
EP2731603A1 (en) | 2014-05-21 |
EA201490233A8 (ru) | 2015-01-30 |
AP2014007413A0 (en) | 2014-02-28 |
JP2014522856A (ja) | 2014-09-08 |
WO2013008218A1 (en) | 2013-01-17 |
EA201490233A1 (ru) | 2014-07-30 |
CA2850089A1 (en) | 2013-01-17 |
MX2014000463A (es) | 2014-07-09 |
CN103930107A (zh) | 2014-07-16 |